Dhanvantri Jeevan Rekha Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2026 ,inter alia, to consider and approve To Consider and adopt ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Dhanvantri Jeevan Rekha Ltd (Scrip Code: 531043), which operates Dhanvantri Hospital in Meerut, has informed BSE about a Board of Directors meeting scheduled for Thursday, 12 February 2026 at 12:00 PM. The intimation has been filed under Regulation 29 of SEBI's Listing Obligations and Disclosure Requirements Regulations, 2015. The specific agenda items are truncated in the available document, but the headline suggests it may include matters to 'consider and adopt,' which typically relates to financial results or other key approvals. The filing was made by Ritika Bhandari, Company Secretary and Compliance Officer, on 5 February 2026 from Meerut.
This is a routine procedural filing with no immediate impact on share price. Investors should watch for the outcome of the 12 February 2026 meeting, as board meetings under Regulation 29 usually precede the announcement of financial results or material corporate actions that could affect the stock.